In this Finished Goods Traceability Use Case presentation, you will find:
- An introduction to Finished Goods Traceability use case presented Dr Jan Wortmann (Bayer) and Bernhard Salbe (Roche)
- The current pharma supply chain process and its disadvantages
- Finished Goods Traceability PharmaLedger blockchain vision
- Value proposition to actors involved
You can also read more about Finished Goods Traceability and rewatch our #1 Open Webinar video recording including the Q&A on this topic by clicking on the button below:
View the full #1 Open Webinar presentation, which includes all four supply chain use cases.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.